A phase II trial of high-dose hydroxyurea administered parenterally in patients with epithelial ovarian carcinoma refractory to platinum

Authors
Category Primary study
JournalInternational Journal of Gynecological Cancer
Year 1998
This article has no abstract
Epistemonikos ID: b1dce40e34b383a593df9afaeee864abb426ca6b
First added on: Feb 03, 2025